Ori Braitbard

500 total citations
18 papers, 423 citations indexed

About

Ori Braitbard is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ori Braitbard has authored 18 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Ori Braitbard's work include Metal complexes synthesis and properties (9 papers), Virus-based gene therapy research (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Ori Braitbard is often cited by papers focused on Metal complexes synthesis and properties (9 papers), Virus-based gene therapy research (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Ori Braitbard collaborates with scholars based in Israel, United States and Italy. Ori Braitbard's co-authors include Edit Y. Tshuva, Jacob Hochman, Sigalit Meker, Cesar M. Manna, Matthew D. Hall, Shlomo Magdassi, Katrin Margulis‐Goshen, Naamah Bloch, Baruh Polis and Abraham O. Samson and has published in prestigious journals such as Inorganic Chemistry, Chemistry - A European Journal and Molecules.

In The Last Decade

Ori Braitbard

18 papers receiving 420 citations

Peers

Ori Braitbard

ONCOL

OC

IC

MB

MC

Ila Pant India

Zhenfan Wen China

Zhikui Li China

Akanksha Dixit India

Joana Silva Portugal

Susana Santos Portugal

Kai-Di Zhao China

Jorge Serment-Guerrero Mexico

Maëlle Monteil France

Hamsell M. Alvarez United States

Ila Pant India

Ori Braitbard

227 ×0.9

ONCOL

119 ×0.8

OC

79 ×0.7

IC

129 ×1.5

MB

152 ×1.8

MC

Citations per year, relative to Ori Braitbard Ori Braitbard (= 1×) peers Ila Pant

Countries citing papers authored by Ori Braitbard

Since Specialization

Citations

This map shows the geographic impact of Ori Braitbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ori Braitbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ori Braitbard more than expected).

Fields of papers citing papers by Ori Braitbard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ori Braitbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ori Braitbard. The network helps show where Ori Braitbard may publish in the future.

Co-authorship network of co-authors of Ori Braitbard

This figure shows the co-authorship network connecting the top 25 collaborators of Ori Braitbard. A scholar is included among the top collaborators of Ori Braitbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ori Braitbard. Ori Braitbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Hochman, Jacob & Ori Braitbard. (2022). Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide—From Murine Lymphoma to Human Breast Cancer. Viruses. 14(11). 2435–2435. 2 indexed citations

2.

Bloch, Naamah, et al.. (2021). Towards a Consensus on Alzheimer’s Disease Comorbidity?. Journal of Clinical Medicine. 10(19). 4360–4360. 36 indexed citations

3.

Braun, Maya, Emiliano Cohen, Ori Braitbard, et al.. (2020). Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug. iScience. 23(7). 101262–101262. 27 indexed citations

4.

Braitbard, Ori, et al.. (2020). Effective Oral Administration of an Antitumorigenic Nanoformulated Titanium Complex. ChemMedChem. 16(1). 108–112. 13 indexed citations

5.

Lawson, James S., Chiara Maria Mazzanti, Prospero Civita, et al.. (2018). Association of Mouse Mammary Tumor Virus With Human Breast Cancer: Histology, Immunohistochemistry and Polymerase Chain Reaction Analyses. Frontiers in Oncology. 8. 141–141. 17 indexed citations

6.

Meker, Sigalit, Ori Braitbard, Matthew D. Hall, Jacob Hochman, & Edit Y. Tshuva. (2016). Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents. Chemistry - A European Journal. 22(29). 9849–9849. 5 indexed citations

7.

Braitbard, Ori, et al.. (2016). Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity. Journal of Inorganic Biochemistry. 163. 250–257. 27 indexed citations

8.

Meker, Sigalit, Ori Braitbard, Matthew D. Hall, Jacob Hochman, & Edit Y. Tshuva. (2016). Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents. Chemistry - A European Journal. 22(29). 9986–9995. 40 indexed citations

9.

Braitbard, Ori, Maayan Roniger, Sara Franceschi, et al.. (2016). A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers. Oncotarget. 7(16). 21168–21180. 16 indexed citations

10.

Meker, Sigalit, Ori Braitbard, Katrin Margulis‐Goshen, et al.. (2015). Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity. Molecules. 20(10). 18526–18538. 21 indexed citations

11.

Braitbard, Ori, et al.. (2015). Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents. Inorganic Chemistry. 55(2). 610–618. 53 indexed citations

12.

Meker, Sigalit, Katrin Margulis‐Goshen, Ori Braitbard, et al.. (2014). Anti‐proliferative Activity of Nano‐Formulated Phenolato Titanium(IV) Complexes Against Cancer Cells. ChemMedChem. 9(6). 1294–1298. 26 indexed citations

13.

Roniger, Maayan, et al.. (2012). The Signal Peptide of Mouse Mammary Tumor Virus-Env: A Phosphoprotein Tumor Modulator. Molecular Cancer Research. 10(8). 1077–1086. 20 indexed citations

14.

Wellhöner, Hans H., Aryeh Weiss, Axel Schulz, et al.. (2012). Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates. Journal of drug targeting. 20(5). 445–452. 7 indexed citations

15.

Manna, Cesar M., et al.. (2012). Cytotoxic Salan–Titanium(IV) Complexes: High Activity Toward a Range of Sensitive and Drug‐Resistant Cell Lines, and Mechanistic Insights. ChemMedChem. 7(4). 703–708. 50 indexed citations

16.

Braitbard, Ori, et al.. (2012). Highly cytotoxic vanadium(v) complexes of salan ligands; insights on the role of hydrolysis. Dalton Transactions. 41(17). 5241–5241. 45 indexed citations

17.

Braitbard, Ori, et al.. (2006). Competition between bound and free peptides in an ELISA-based procedure that assays peptides derived from protein digests.. Proteome Science. 4(1). 12–12. 12 indexed citations

18.

Braitbard, Ori, et al.. (2006). An ELISA-based procedure for assaying proteins in digests of human leukocytes and cell lines, using specifically selected peptides and appropriate antibodies. Proteome Science. 4(1). 14–14. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact